Insider · CIK 0001617239
Tomasello Shawn
Reports to the SEC for 11 companies · EMERYVILLE, CA
Transactions
50
Companies
11
Filings
14
CIK
0001617239
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2026-06-17 | FDMT4D Molecular Therapeutics, Inc. · Stock Option (Right to Buy)A Award | — |
| 2026-06-09 | CABACabaletta Bio, Inc. · Stock Option (Right to Buy)A Award | — |
| 2026-01-21 | CABACabaletta Bio, Inc.P Purchase | +$50.3K |
| 2025-06-17 | FDMT4D Molecular Therapeutics, Inc. · Stock Option (Right to Buy)A Award | — |
| 2025-06-09 | CABACabaletta Bio, Inc. · Stock Option (Right to Buy)A Award | — |
| 2025-05-19 | CABACabaletta Bio, Inc. · Stock Option (Right to Buy)D Disposition to Issuer | — |
| 2025-05-19 | CABACabaletta Bio, Inc. · Stock Option (Right to Buy)A Award | — |
| 2025-05-19 | CABACabaletta Bio, Inc. · Stock Option (Right to Buy)D Disposition to Issuer | — |
| 2025-05-19 | CABACabaletta Bio, Inc. · Stock Option (Right to Buy)A Award | — |
| 2024-06-06 | KLRSKalaris Therapeutics, Inc.A Award | — |
| 2024-06-03 | CABACabaletta Bio, Inc. · Stock Option (Right to Buy)A Award | — |
| 2024-05-21 | FDMT4D Molecular Therapeutics, Inc. · Stock Option (Right To Buy)A Award | — |
| 2024-01-31 | Gamida Cell Ltd.A Award | — |
| 2023-10-19 | Gamida Cell Ltd.A Award | — |
| 2023-10-19 | Gamida Cell Ltd.Share Option (Right to Buy)A Award | — |
| 2023-10-19 | Gamida Cell Ltd.Share Option (Right to Buy)A Award | — |
| 2023-07-21 | CABACabaletta Bio, Inc. · Stock Option (Right to Buy)A Award | — |
| 2023-06-01 | TCR2 THERAPEUTICS INC.Stock Option (Right to Buy)D Disposition to Issuer | — |
| 2023-06-01 | TCR2 THERAPEUTICS INC.Stock Option (Right to Buy)D Disposition to Issuer | — |
| 2023-06-01 | TCR2 THERAPEUTICS INC.Stock Option (Right to Buy)D Disposition to Issuer | — |
| 2023-06-01 | TCR2 THERAPEUTICS INC.Stock Option (Right to Buy)D Disposition to Issuer | — |
| 2023-05-23 | FDMT4D Molecular Therapeutics, Inc. · Stock Option (Right to Buy)A Award | — |
| 2023-05-11 | KLRSKalaris Therapeutics, Inc.A Award | — |
| 2023-03-20 | Gamida Cell Ltd.Share Option (Right to Buy)A Award | — |
| 2023-02-08 | Gamida Cell Ltd.A Award | — |
| 2023-02-08 | Gamida Cell Ltd.Share Option (Right to Buy)A Award | — |
| 2022-12-15 | TCR2 THERAPEUTICS INC.Stock Option (Right to Buy)A Award | — |
| 2022-11-18 | Gamida Cell Ltd.A Award | — |
| 2022-11-18 | Gamida Cell Ltd.Share Option (Right to Buy)A Award | — |
| 2022-09-30 | Gamida Cell Ltd.P Purchase | +$15K |
| 2022-05-23 | FDMT4D Molecular Therapeutics, Inc. · Stock Option (Right to Buy)A Award | — |
| 2022-05-17 | KLRSKalaris Therapeutics, Inc. · Stock Option (Right to Buy)A Award | — |
| 2022-03-29 | KLRSKalaris Therapeutics, Inc. · Stock Option (Right to Buy)A Award | — |
| 2021-12-09 | TCR2 THERAPEUTICS INC.Stock Option (Right to Buy)A Award | — |
| 2021-06-07 | URGNUroGen Pharma Ltd. · Stock Option (right to buy)A Award | — |
| 2021-05-17 | FDMT4D Molecular Therapeutics, Inc. · Stock Option (Right to Buy)A Award | — |
| 2021-02-03 | TCR2 THERAPEUTICS INC.Stock Option (Right to Buy)A Award | — |
| 2021-02-03 | TCR2 THERAPEUTICS INC.Stock Option (Right to Buy)A Award | — |
| 2020-09-28 | Principia Biopharma Inc.Director Stock Option (right to buy)D Disposition to Issuer | — |
| 2020-09-28 | Principia Biopharma Inc.Director Stock Option (right to buy)D Disposition to Issuer | — |
| 2020-06-08 | URGNUroGen Pharma Ltd. · Stock Option (right to buy)A Award | — |
| 2020-06-04 | Principia Biopharma Inc.Director Stock Option (right to buy)A Award | — |
| 2020-05-20 | ABEOABEONA THERAPEUTICS INC.A Award | — |
| 2020-05-20 | ABEOABEONA THERAPEUTICS INC. · Stock Option (right to buy)A Award | — |
| 2020-02-10 | Diplomat Pharmacy, Inc.U Disposition from Tender | −$45.1K |
| 2020-02-10 | Diplomat Pharmacy, Inc.D Disposition to Issuer | −$133K |
| 2019-10-02 | Diplomat Pharmacy, Inc.S Sale | −$4,157.56 |
| 2019-08-29 | Principia Biopharma Inc.Director Stock Option (right to buy)A Award | — |
| 2019-08-29 | Principia Biopharma Inc.Director Stock Option (right to buy)A Award | — |
| 2019-08-29 | Principia Biopharma Inc.Director Stock Option (right to buy)A Award | — |
Recent filings
- 4Tomasello Shawn0001193125-26-276168SEC(opens sec.gov)
- 4Tomasello Shawn0001193125-26-266239SEC(opens sec.gov)
- 4Tomasello Shawn0001193125-26-018324SEC(opens sec.gov)
- 4Tomasello Shawn0000950170-25-088489SEC(opens sec.gov)
- 4Tomasello Shawn0000950170-25-084015SEC(opens sec.gov)
- 4Tomasello Shawn0000950170-25-074823SEC(opens sec.gov)
- 4Tomasello Shawn0000950170-24-070596SEC(opens sec.gov)
- 4Tomasello Shawn0000950170-24-068982SEC(opens sec.gov)
- 4Tomasello Shawn0000950170-24-064259SEC(opens sec.gov)
- 4Tomasello Shawn0001415889-24-002335SEC(opens sec.gov)
- 4/ATomasello Shawn0001209191-23-053267SEC(opens sec.gov)
- 4/ATomasello Shawn0001209191-23-053265SEC(opens sec.gov)
- 4Tomasello Shawn0000950170-23-033944SEC(opens sec.gov)
- 4Tomasello Shawn0001104659-23-067078SEC(opens sec.gov)
Companies
- 4D Molecular Therapeutics, Inc.DirectorFDMT
- ABEONA THERAPEUTICS INC.DirectorABEO
- Cabaletta Bio, Inc.DirectorCABA
- Diplomat Pharmacy, Inc.Director
- Gamida Cell Ltd.Director
- Kalaris Therapeutics, Inc.DirectorKLRS
- Kite Pharma, Inc.Chief Commercial Officer
- PHARMACYCLICS INCChief Commercial Officer
- Principia Biopharma Inc.Director
- TCR2 THERAPEUTICS INC.Director
- UroGen Pharma Ltd.DirectorURGN
Address
C/O 4D MOLECULAR THERAPEUTICS, INC. 5858 HORTON STREET #455
EMERYVILLE, CA, 94608